glp-1 solution oral Scam weight-loss drops marketed to Australians contain 'basically salty water', analysis finds | Scams Oral GLP-1 Drops – BloomMD

Diabetes 71 , 11151127 (2022)

Most people who stop taking GLP-1 drugs gain back some or all of their lost weight, because the effects on hunger and metabolism go away when the medicine is stopped

But they were reporting the opposite

In September 2024, Becton, Dickinson and Company introduced the BD Neopak XtraFlow Glass Prefillable Syringe and expanded the capacity of its BD Neopak Glass Prefillable Syringe platform to address the growing demand for biologic therapies

Development and Approval: As of early 2023, tirzepatide is approved only for the treatment of type 2 diabetes

For example, combining semaglutide with medications that have anti-inflammatory properties might help prevent or lessen skin problems